Skip to main content

International Vaccine Access Center

Featured

Vaccine vial with syringe

Preventing Cancer: The Far-Reaching Impact of Vaccines

For World Cancer Day, we highlight vaccines that have been shown to effectively protect against cancer-causing viruses, including human papillomavirus (HPV) and hepatitis B virus (HBV).

Healthcare bill with stethoscope

The Economic Impact of the Ongoing Measles Outbreak

Beyond the devastating health impacts, measles outbreaks can have significant financial implications. As the number of measles cases in the United States continues to grow, so too does the price tag associated with this outbreak.

Interventions to protect infants and older adults against RSV could avert 17% of hospitalizations this season

RSV Vaccines Projected to Protect Infants and Seniors This Season

Based on the latest projections from the RSV Scenario Modeling Hub, between July 2024 and June 2025, interventions are expected to avert thousands of cases of severe disease that would require hospitalization.

Vaccine vials

Accelerating global access to life-saving vaccines.

We apply rigorous science to build knowledge and support for the value of vaccines.

IVAC's Work

The International Vaccine Access Center accelerates equitable and sustainable access to vaccines in low- and middle-income countries by generating, synthesizing, and using evidence to inform decision making and action.

Where We Work

 IVAC works with governments and major research institutions in 38 countries. Learn more about us.

World map identifying countries where IVAC currently has projects

What We Do: Project Highlights

Vaccine Information and Epidemiology Window (VIEW-HUB)
VIEW-hub is IVAC’s publicly accessible interactive platform to visualize real-time information on vaccine use, product type, coverage levels, impact assessments, and disease burden estimates. It can be utilized to track progress and strategize ways to accelerate and optimize vaccine implementation.
READ MORE>

Vaccine Economics Research for Sustainability & Equity (VERSE)
VERSE will compute the economic benefits and return-on-investment of vaccines, create a standardized model for assessing, tracking, and targeting vaccine coverage inequity at the country level and for monetizing the economic losses due to inequity, and more.
READ MORE >

More Projects

Stay Connected

Sign up for our monthly newsletter to receive the latest updates on immunization-related science, policy, and access from the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health.